ADXN

Addex Therapeutics Ltd

Price Chart

No historical data available

Latest Quote

$3.84

-0.01 (-0.26%)

Current Price

Previous Close	$3.85
Open	$3.97
Day High	$4.07
Day Low	$3.83
Volume	21,607

Fetched: 2026-08-30T19:48:34

Stock Information

Note: Financial values converted from CHF to USD

Shares Outstanding	1.27M
Total Debt	$126K
Cash Equivalents	$1.16M
Revenue	$135K
Net Income	$-8.75M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$4.86M
EPS (TTM)	$-8.94
Exchange	NCM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About Addex Therapeutics Ltd

Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes. Its lead programs include Dipraglurant, which is in phase 1 clinical trial for the treatment of post-stroke/TBI recovery, as well as to treat Parkinson's disease levodopa-induced dyskinesia. The company also develops ADX71149, which is in phase 1 for undisclosed indication; and GABAB PAM for the treatment pain, anxiety, addiction, chronic cough, and overactive bladder. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. for the develop mGlu2 PAM compounds for the treatment of human health; and license and research agreement with Indivior PLC discovery, development, and commercialization of novel GABAB PAM compounds for the treatment of addiction and other CNS diseases. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is based in Geneva, Switzerland.

📰 Latest News

No news articles available at the moment. Check back later for updates on ADXN.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$37,302	$502,927	$2,007,409	$1,770,302
Operating Revenue	$37,302	$502,927	$2,007,409	$1,770,302
Expenses
Interest Expense	$3,013	$4,414	$4,810	$34,780
Total Expenses	$3,540,224	$3,931,966	$4,798,905	$14,889,035
Other Income Expense	$-5,010,042	$-2,687,899	$-394,879	$-329,011
Net Non Operating Interest Income Expense	$-3,013	$6,992	$74,797	$1,624
Interest Expense Non Operating	$3,013	$4,414	$4,810	$34,780
Operating Expense	$3,540,224	$3,931,966	$4,798,905	$14,889,035
Other Operating Expenses	$943,345	$1,065,678	$1,083,377	$1,006,819
General And Administrative Expense	$2,349,633	$2,084,849	$2,527,643	$4,059,769
Rent Expense Supplemental	-	-	$44,265	$58,846
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-8,515,978	$-6,109,947	$-3,111,578	$-13,446,119
Net Interest Income	$-3,013	$6,992	$74,797	$1,624
Interest Income	$0	$11,406	$79,607	$36,404
Normalized Income	$-8,499,642	$-6,131,639	$-2,716,700	$-13,117,108
Net Income From Continuing And Discontinued Operation	$-8,373,673	$8,781,316	$-13,137,806	$-25,891,989
Total Operating Income As Reported	$-3,502,922	$-3,429,039	$-2,791,496	$-13,118,732
Net Income Common Stockholders	$-8,373,673	$8,781,316	$-13,137,806	$-25,891,989
Net Income	$-8,373,673	$8,781,316	$-13,137,806	$-25,891,989
Net Income Including Noncontrolling Interests	$-8,373,673	$8,781,316	$-13,137,806	$-25,891,989
Net Income Discontinuous Operations	$142,305	$14,891,262	$-10,026,228	$-12,445,871
Net Income Continuous Operations	$-8,515,978	$-6,109,947	$-3,111,578	$-13,446,119
Pretax Income	$-8,515,978	$-6,109,947	$-3,111,578	$-13,446,119
Earnings From Equity Interest	$-4,993,706	$-2,709,592	$0	$0
Interest Income Non Operating	$0	$11,406	$79,607	$36,404
Operating Income	$-3,502,922	$-3,429,039	$-2,791,496	$-13,118,732
Depreciation Amortization Depletion Income Statement	$10,544	$239,823	$14,626	$10,970
Depreciation And Amortization In Income Statement	$10,544	$239,823	$14,626	$10,970
Depreciation Income Statement	$10,544	$239,823	$14,626	$10,970
Per Share
Diluted EPS	$-8.96	$10.45	$-20.91	$-68.70
Basic EPS	$-8.96	$10.45	$-20.91	$-68.70
Other
Tax Effect Of Unusual Items	$0	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-8,486,085	$-5,803,491	$-2,331,115	$-12,680,157
Total Unusual Items	$-16,336	$21,693	$-394,879	$-329,011
Total Unusual Items Excluding Goodwill	$-16,336	$21,693	$-394,879	$-329,011
Reconciled Depreciation	$10,544	$323,734	$380,774	$402,171
EBITDA (Bullshit earnings)	$-8,502,421	$-5,781,799	$-2,725,994	$-13,009,168
EBIT	$-8,512,965	$-6,105,532	$-3,106,768	$-13,411,338
Diluted Average Shares	$1,113,581	$1,017,557	$770,666	$852,894
Basic Average Shares	$1,113,581	$1,017,557	$770,666	$468,626
Diluted NI Availto Com Stockholders	$-8,373,673	$8,781,316	$-13,137,806	$-25,891,989
Tax Provision	$0	$0	$0	$0
Gain On Sale Of Security	$-16,336	$21,693	$-394,879	$-329,011
Research And Development	$236,702	$541,617	$1,173,260	$9,811,478
Selling General And Administration	$2,349,633	$2,084,849	$2,527,643	$4,059,769
Other Gand A	$1,636,414	$1,501,945	$1,448,462	$1,764,414
Insurance And Claims	$228,800	$280,986	$782,321	$1,980,375
Salaries And Wages	$484,418	$301,918	$296,860	$314,979
Rent And Landing Fees	-	-	$44,265	$58,846

Fetched: 2026-08-28

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$5,932,411	$12,043,897	$1,425,594	$6,114,388
Total Assets	$7,920,687	$13,289,736	$5,777,082	$10,307,468
Total Non Current Assets	$5,829,680	$8,882,315	$506,882	$563,894
Non Current Prepaid Assets	$8,819	$8,823	$67,634	$67,648
Financial Assets	$633,562	$0	-	-
Investmentin Financial Assets	$355,895	$0	-	-
Goodwill And Other Intangible Assets	$0	$0	-	-
Current Assets	$2,091,007	$4,407,421	$5,270,199	$9,743,573
Prepaid Assets	$20,280	$211,138	$270,078	$336,520
Receivables	$24,999	$19,307	$188,261	$744,637
Accounts Receivable	$24,999	$19,307	$137,350	$518,824
Cash Cash Equivalents And Short Term Investments	$2,045,727	$4,167,062	$4,811,859	$8,662,416
Cash And Cash Equivalents	$2,039,343	$4,158,977	$4,810,804	$8,658,477
Cash Financial	$2,039,343	$4,158,977	$4,810,804	$8,658,477
Other Current Assets	-	$9,915	-	-
Other Receivables	-	-	$50,911	$225,813
Current Deferred Assets	-	-	-	-
Debt
Total Debt	$43,171	$52,264	$428,545	$464,387
Long Term Debt And Capital Lease Obligation	$33,613	$43,171	$87,592	$108,311
Current Debt And Capital Lease Obligation	$9,558	$9,093	$340,953	$356,076
Liabilities
Total Liabilities Net Minority Interest	$1,988,276	$1,245,839	$4,351,487	$4,193,079
Total Non Current Liabilities Net Minority Interest	$496,100	$247,591	$750,636	$108,311
Current Liabilities	$1,492,177	$998,249	$3,600,851	$4,084,768
Payables And Accrued Expenses	$1,482,619	$989,156	$2,967,455	$3,728,692
Payables	$804,845	$343,421	$1,429,985	$1,739,167
Total Tax Payable	$54,502	$28,188	$204,865	$150,436
Accounts Payable	$750,344	$315,233	$1,225,120	$1,588,732
Non Current Deferred Liabilities	-	$0	$111,054	$0
Current Deferred Liabilities	-	$0	$292,443	$0
Other Payable	-	-	-	$150,436
Equity
Common Stock Equity	$5,932,411	$12,043,897	$1,425,594	$6,114,388
Total Equity Gross Minority Interest	$5,932,411	$12,043,897	$1,425,594	$6,114,388
Stockholders Equity	$5,932,411	$12,043,897	$1,425,594	$6,114,388
Other Equity Interest	$80,423,428	$80,423,428	$80,423,428	$80,423,428
Gains Losses Not Affecting Retained Earnings	$39,523,873	$38,659,610	$37,106,181	$32,070,160
Other Equity Adjustments	$39,523,873	$38,659,610	$37,106,181	$32,070,160
Retained Earnings	$-448,152,718	$-439,779,046	$-448,560,361	$-435,422,555
Long Term Equity Investment	$4,788,794	$8,820,339	$0	-
Other
Treasury Shares Number	$125,360,765	$107,046,418	$110,912,149	$47,559,791
Ordinary Shares Number	$146,766,804	$122,392,910	$118,527,179	$95,997,538
Share Issued	$272,127,568	$229,439,328	$229,439,328	$143,557,329
Tangible Book Value	$5,932,411	$12,043,897	$1,425,594	$6,114,388
Invested Capital	$5,932,411	$12,043,897	$1,425,594	$6,114,388
Working Capital	$598,830	$3,409,172	$1,669,348	$5,658,805
Capital Lease Obligations	$43,171	$52,264	$428,545	$464,387
Total Capitalization	$5,932,411	$12,043,897	$1,425,594	$6,114,388
Treasury Stock	$1,263,199	$1,082,400	$1,132,005	$7,814,267
Additional Paid In Capital	$332,679,751	$331,527,911	$331,293,958	$335,422,049
Capital Stock	$2,721,276	$2,294,393	$2,294,393	$1,435,573
Common Stock	$2,721,276	$2,294,393	$2,294,393	$1,435,573
Employee Benefits	$462,487	$204,419	$551,990	$0
Non Current Pension And Other Postretirement Benefit Plans	$462,487	$204,419	$551,990	$0
Long Term Capital Lease Obligation	$33,613	$43,171	$87,592	$108,311
Current Capital Lease Obligation	$9,558	$9,093	$340,953	$356,076
Current Accrued Expenses	$677,774	$645,735	$1,537,470	$1,989,525
Investments And Advances	$5,144,690	$8,820,339	$0	-
Available For Sale Securities	$355,895	-	-	-
Investmentsin Associatesat Cost	$4,788,794	$8,820,339	$0	-
Net PPE	$42,610	$53,154	$439,248	$496,246
Accumulated Depreciation	$-201,842	$-191,298	$-5,378,654	$-4,997,879
Gross PPE	$244,452	$244,452	$5,817,902	$5,494,126
Leases	$138,945	$138,945	$2,147,059	$1,831,798
Other Properties	$105,507	$105,507	$3,661,429	$3,652,914
Properties	$0	$0	$0	$0
Other Short Term Investments	$6,385	$8,085	$1,055	$3,939
Non Current Deferred Revenue	-	$0	$111,054	$0
Current Deferred Revenue	-	$0	$292,443	$0
Machinery Furniture Equipment	-	$0	$9,414	$9,414

Fetched: 2026-08-28

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-2,702,075	$-6,689,268	$-9,955,511	$-20,457,706
Operating Activities
Operating Cash Flow	$-2,702,075	$-6,687,684	$-9,946,996	$-20,456,982
Cash Flow From Continuing Operating Activities	$-2,702,075	$-6,687,684	$-9,946,996	$-20,456,982
Operating Gains Losses	$4,842,418	$-14,762,486	$-77,963	$-14,179
Investing Activities
Investing Cash Flow	$-847,152	$5,781,221	$-8,515	$3,699
Cash Flow From Continuing Investing Activities	$-847,152	$5,781,221	$-8,515	$3,699
Capital Expenditure	-	$-1,584	$-8,515	$-723
Net Other Investing Changes	-	$-589,011	-	-
Financing Activities
Repurchase Of Capital Stock	$-35,905	$-32,087	$-59,802	$-4,340
Issuance Of Capital Stock	$1,529,226	$299,812	$2,925,342	$2,085,708
Financing Cash Flow	$1,473,384	$130,576	$6,552,080	$3,861,466
Cash Flow From Continuing Financing Activities	$1,473,384	$130,576	$6,552,080	$3,861,466
Net Other Financing Charges	$-7,831	$11,406	$12,899	$-651,042
Cash Dividends Paid	$0	$0	$0	$0
Net Common Stock Issuance	$1,493,321	$267,725	$2,865,540	$2,081,368
Common Stock Issuance	$1,529,226	$299,812	$2,925,342	$2,085,708
Other
Repayment Of Debt	$-9,093	$-91,709	$-350,707	$-358,526
End Cash Position	$2,039,343	$4,158,977	$4,810,804	$8,658,477
Beginning Cash Position	$4,158,977	$4,810,804	$8,658,477	$25,494,507
Effect Of Exchange Rate Changes	$-43,791	$124,060	$-444,241	$-244,213
Changes In Cash	$-2,075,843	$-775,887	$-3,403,431	$-16,591,817
Interest Paid Cff	$-3,013	$-11,474	$-26,891	$-60,855
Proceeds From Stock Option Exercised	$0	$-45,373	$4,051,240	$2,850,522
Common Stock Payments	$-35,905	$-32,087	$-59,802	$-4,340
Net Issuance Payments Of Debt	$-9,093	$-91,709	$-350,707	$-358,526
Net Long Term Debt Issuance	$-9,093	$-91,709	$-350,707	$-358,526
Long Term Debt Payments	$-9,093	$-91,709	$-350,707	$-358,526
Net Investment Purchase And Sale	$-989,457	$0	$0	$4,422
Purchase Of Investment	$-989,457	$0	$0	-
Net Business Purchase And Sale	$142,305	$6,371,816	$0	$0
Sale Of Business	$142,305	$6,371,816	$0	-
Net PPE Purchase And Sale	$0	$-1,584	$-8,515	$-723
Purchase Of PPE	$0	$-1,584	$-8,515	$-723
Change In Working Capital	$683,693	$-1,528,774	$266,031	$196,238
Change In Other Current Assets	$11,615	$-16,945	$2,884	$17,399
Change In Payables And Accrued Expense	$486,912	$-1,426,365	$-763,167	$-531,908
Change In Prepaid Assets	$190,858	$-204,460	$66,442	$1,051,624
Change In Receivables	$-5,693	$166,788	$556,376	$-340,877
Changes In Account Receivables	$-5,693	$115,877	$381,474	$-313,740
Other Non Cash Items	$134,943	$498,526	$2,621,968	$4,850,778
Depreciation Amortization Depletion	$10,544	$323,734	$380,774	$402,171
Depreciation And Amortization	$10,544	$323,734	$380,774	$402,171
Depreciation	$10,544	$323,734	$380,774	$402,171
Pension And Employee Benefit Expense	$-8,983	$-118,505	$-77,963	$-14,179
Earnings Losses From Equity Investments	$4,993,706	$2,709,592	$0	$0
Gain Loss On Sale Of Business	$-142,305	$-17,353,572	$0	$0
Net Income From Continuing Operations	$-8,373,673	$8,781,316	$-13,137,806	$-25,891,989
Sale Of Investment	-	$0	$0	$4,422
Purchase Of Business	-	$-589,011	$0	$0
Change In Other Working Capital	-	$-47,792	$403,497	-
Stock Based Compensation	-	-	-	$4,582,543
Gain Loss On Sale Of PPE	-	-	-	$0

Fetched: 2026-08-28